Technical guides for research customers.
Original long-form articles on peptide quality control, salt forms, stability, and how to evaluate a peptide supplier. Written for lab buyers and informed research customers.
Quality Control
How peptide quality is measured, documented, and verified.
What the published safety record actually says
Reported adverse effects, and the much more important fact of how little controlled human data exists behind them. What is documented, what is self-reported, and what has never been studied.
A Certificate of Analysis in your name — what it covers
A re-issued COA changes whose letterhead the data appears on. It does not change the data, the lot, or who performed the analysis — and claiming otherwise is where operators get into trouble.
How to read the chromatogram on a peptide COA
The purity number is a summary of the trace. Reading the trace itself catches things the number hides — shoulders, baseline drift and a peak too early to trust.
What is in a peptide stack, and what the research covers
A stack is several separate vials bought together, not a mixed product. What each of ours contains, and why the literature belongs to the components.
How to verify a blend COA when there is no single molecule
Every COA convention assumes one compound. Blends break all of them. What purity, mass confirmation and peptide content mean when a vial holds three peptides.
How to read a peptide Certificate of Analysis
The five numbers that actually matter on a peptide COA, what they mean, and the red flags that should make you choose a different supplier.
HPLC vs mass spec vs amino acid analysis — what each test proves
A practical guide to the three peptide QC methods, what each can prove and disprove, and why a complete QC profile requires all three.
Peptide purity thresholds — 95%, 98%, 99% and what each is good for
What HPLC area-percent purity levels actually mean for downstream applications, why "higher is better" is not always true, and the cost trade-offs.
Cloudy, clumped or undissolved — diagnosing a failed reconstitution
Four appearances, four different causes. What a hazy vial, a gel, floating strands or a stubborn cake each tell you about the material and the technique.
Identification
Salt forms, counter-ions, CAS numbers, and how to verify what's in the vial.
Epitalon — identity, chemistry and what the literature examined
A four-residue peptide at 390 g/mol, among the smallest compounds in the research market. CAS, formula, sequence, and what the published work actually studied.
Thymosin Alpha-1 — identity and the clinical literature
A 28-residue N-acetylated thymic peptide with more clinical literature behind it than almost any compound in this market. Identity data and what the studies covered.
LL-37 (Cathelicidin) — identity and handling of a cationic peptide
37 residues carrying an unusually high positive charge. That charge governs its solubility, its adsorption to surfaces, and why it needs different labware.
PT-141 (Bremelanotide) — a cyclic peptide, and why that matters
Bremelanotide is cyclised head-to-side-chain, not linear. The ring changes its stability, its analysis, and what a COA can and cannot confirm.
Kisspeptin-10 — what the (45-54) in the name means
Kisspeptin is a family, not a molecule. The number after the name tells you which fragment is in the vial, and the fragments differ by thousands of daltons.
CJC-1295 with DAC — the other molecule, and how to tell them apart
The DAC form is 279 daltons heavier than the no-DAC form and has its own CAS. One number on the COA separates them.
Sermorelin — GHRH (1-29) and the peptide family built on it
Sermorelin is the unmodified first 29 residues of growth hormone releasing hormone. Every GHRH analog in this market is a modification of it.
Semax — an ACTH fragment with a Pro-Gly-Pro tail
Semax is ACTH (4-7) with a proline-glycine-proline tail attached. That tail is a design decision shared with Selank, and it explains both compounds.
Selank — a tuftsin analog, and the tail it shares with Semax
Selank is tuftsin with the same Pro-Gly-Pro tail Semax carries. Two compounds, one structural idea, and no methionine to worry about.
Dihexa — why it is not really a peptide
Dihexa is an angiotensin IV analog built with non-amino-acid components. Peptide COA conventions apply to it only partly, and that trips people up.
What is the Wolverine blend? BPC-157 and TB-500
Wolverine blend is a market nickname for a BPC-157 and TB-500 pairing. What is in the vial, what the research covers, what the record says about safety, and what the dosing question actually turns on.
What is the super human blend? Why there is no standard one
Super human blend has no agreed formulation — the same name covers different vials from different suppliers. What is usually in one, what the research covers, and how to compare two of them.
KLOW and GLOW blends — what is in each and how they differ
KLOW is GHK-Cu, BPC-157, TB-500 and KPV. GLOW is the same minus KPV. What the fourth component changes and how the totals divide.
BPC-157 reference — identity, stability, handling
CAS, molecular weight and sequence for BPC-157, why its amino acid composition makes it unusually stable, and what a complete COA should show.
TB-500 and thymosin beta-4 — what you are actually buying
TB-500 and thymosin beta-4 are used interchangeably by suppliers but originally named different molecules. How to tell from the COA which one is in the vial.
GHK-Cu — handling a copper complex, not a plain peptide
GHK-Cu is a tripeptide bound to a copper(II) ion. The metal changes the mass, the colour, the light sensitivity and what a purity figure even means.
KPV — what changes when a peptide is only three residues
At 389 g/mol KPV sits at the small end of peptide analysis. Counter-ion is a large mass fraction, and standard peptide QC methods behave differently.
MOTS-c — a peptide encoded outside the nuclear genome
MOTS-c is encoded in mitochondrial 12S rRNA rather than nuclear DNA. What that means for identity checks, and the methionine that governs its handling.
NAD+ is not a peptide — what that changes
NAD+ is a dinucleotide coenzyme, not a peptide. Why the vials are 100 times larger, why it degrades faster in solution, and why peptide COA conventions do not apply.
CJC-1295 with and without DAC — two different molecules
The DAC and no-DAC forms of CJC-1295 are distinct compounds with different masses and different CAS numbers. How to tell which one a COA describes.
Ipamorelin — reading a COA for unnatural residues
Ipamorelin contains Aib, two D-amino acids and a C-terminal amide. Each one changes what standard peptide analysis reports, and how a COA should be read.
TFA vs acetate salt forms — what the counter-ion actually means
The trifluoroacetate vs acetate distinction on a peptide COA, why most labs assume TFA by default, and when the counter-ion matters for reagent work.
Peptide CAS numbers — what they are and how to use them
CAS Registry Numbers for synthetic peptides, how to look them up, and why a supplier's willingness to publish the CAS is a quality-posture signal.
BPC-157 vs TB-500: what actually differs
Two tissue-repair research peptides that are constantly compared. The differences that are real: 3.5× mass gap, different origins, different oxidation risk, different COA questions.
CJC-1295 vs Ipamorelin: two different receptors
The most-compared pair in endocrine research supply act on different receptor families entirely. What that means, plus the 4.7× mass gap and the DAC question.
Tesamorelin vs CJC-1295: two GHRH analogues
Both are GHRH analogues, which makes them genuinely comparable — unlike most pairs. Where they differ: chain length, the N-terminal modification, and regulatory status.
Mono, dual and triple incretin agonists compared
The incretin compounds differ by how many receptors they engage — one, two or three. What that architecture means, and how to verify which molecule is in the vial.
GHK-Cu vs KPV: metal complex or plain peptide
Two small tissue-research peptides with a fundamental difference: one carries a copper ion as part of the compound, the other does not. That changes storage, colour and COA reading.
GLOW 70 — what is actually in the vial
GLOW 70 is 70 mg across three compounds: 50 mg GHK-Cu, 10 mg TB-500, 10 mg BPC-157. The mass split defines the vial — not the name, which no standards body controls.
KLOW 80 — what is actually in the vial
KLOW 80 is 80 mg across four compounds: GHK-Cu, BPC-157, TB-500 and KPV. What the fourth component adds, and why a blend name is not a formulation.
Stability & Storage
Lyophilized and reconstituted peptide stability and storage.
Working out concentration and volume — the arithmetic
Concentration, volume and mass are one equation rearranged three ways. The method, the unit traps, the peptide-content correction, and worked examples you can substitute your own figures into.
Has my peptide gone bad? What you can and cannot tell
Some degradation is visible and some is completely invisible. What appearance actually tells you about a vial, and where looking stops working.
A vial was left out. What that actually costs
The answer depends entirely on whether the vial was lyophilized or reconstituted. For dry material an overnight excursion is usually irrelevant. In solution it is not.
Why the vial looks almost empty — and when that is wrong
A 5 mg cake is a thin film that can be hard to see. What normal looks like, and the cases where an apparently empty vial is a genuine problem.
When water is not enough — choosing a reconstitution solvent
Bacteriostatic water dissolves most research peptides. When it does not, the answer is usually dilute acetic acid — and the reason is the peptide's own charge.
Why one peptide dissolves and the next one gels
Gelling, haze and a stubborn cake are three outcomes of the same property: how the sequence carries charge. What to predict from a peptide before opening the vial.
One large vial or several small ones? Shelf life decides
A lyophilized vial keeps for years; once reconstituted the clock runs in weeks. That asymmetry, not price per milligram, is what should decide the vial size you buy.
Lyophilized peptide storage and stability — practical limits
How long lyophilized peptides actually last in storage, what reconstitution does to that timeline, and the storage practices that preserve shelf life.
Peptide reconstitution math — concentration, volume, and storage
How to calculate the right reconstitution volume to hit a target concentration, why most online "reconstitution calculators" get the math half-right, and the practical pitfalls.
Bacteriostatic vs sterile water — what the benzyl alcohol actually does
Bacteriostatic water contains 0.9% benzyl alcohol; sterile water contains nothing. That single difference decides whether a vial is single-use or multi-use, and how a peptide behaves in it.
Reconstituting a lyophilized vial without losing material
Most reconstitution loss happens in the first ten seconds. The technique that avoids it is unglamorous: aim at the glass, let it dissolve, never shake.
Reconstituted shelf life — what degrades, and how fast
A lyophilized peptide is stable for years. The same peptide in solution is stable for weeks. This is what changes the moment water is added, and what governs the rate.
Freeze-thaw cycles and peptide integrity
Freezing a peptide solution is not free. Each cycle concentrates solutes, shifts pH, and creates ice interfaces — which is why aliquoting beats re-freezing.
Why a lyophilized vial is under vacuum, and what that means for handling
The hiss when you pierce the stopper is the lyophilization cycle finishing its job. It is also a quick integrity check most people waste.
Cold chain and ambient shipping — what actually survives transit
Lyophilized peptides ship ambient for good reason. Here is the science behind that, and what would genuinely warrant a cold pack.
Synthesis
Solid-phase peptide synthesis, scale-up, and reagent chemistry.
Supplier Evaluation
How to evaluate a peptide supplier's quality posture and supply chain.
White label, private label, contract manufacturing — the difference
Three terms used interchangeably that mean different things commercially. Which one you actually want depends on who owns the formulation and who carries the inventory.
Choosing a US peptide supplier for a clinic or store
What separates suppliers when everyone's website says the same thing: where the material is made, who tests it, and what they will put in writing.
Starting a peptide brand — what to have before you order
Most of what decides whether a new brand works is settled before the first vial ships: entity, channel, fulfillment model, documentation, and how much inventory you can actually turn.
What "research use only" actually means for synthetic peptides
The legal and regulatory framing of research-use-only peptides, what the RUO designation does and does not cover, and the supplier obligations that come with it.
How to evaluate a peptide supplier — a buyer's checklist
Twelve questions every research customer should ask a peptide supplier before placing the first order, and what each answer reveals about the vendor's quality posture.
Reference pages
Short, citable references: what the catalogue's coded names denote, and what to check in any supplier.
Coded Product Names Explained
Glossary of Bench Grade Peptides' coded catalogue names (GLP-1 S, GLP-2 T, GLP-3 R, AMY-A) and house blend names: the compound class each name denotes, with links to each product page and its Certificate of Analysis history.
US-Made vs Imported Research Peptides: What to Check
Neutral checklist for any research peptide supplier, US-made or imported: lot-matched Certificates of Analysis, independent laboratories, HPLC purity and mass-spectrometry identity, test dates, and the storage and shipping chain.
Every compound discussed in these guides is supplied by Bench Grade Peptides for laboratory research use only.
Teach or write about lab supply? Our peptide affiliate program for educators and creators pays commission on every order your readers place.